Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

BACKGROUND & AIMS: The long-term immunogenicity of anti-SARS-CoV-2 vaccines in liver transplant (LT) recipients is unknown. We aimed to assess the long-term antibody response of the Pfizer-BioNTech® BNT162b2 vaccine in LT recipients compared to controls. METHODS: LT recipients underwent anti-SAR...

Descripción completa

Detalles Bibliográficos
Autores principales: Toniutto, Pierluigi, Falleti, Edmondo, Cmet, Sara, Cussigh, Annarosa, Veneto, Laura, Bitetto, Davide, Fornasiere, Ezio, Fumolo, Elisa, Fabris, Carlo, Sartor, Assunta, Peressutti, Roberto, Curcio, Francesco, Regattin, Laura, Grillone, Lucrezia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier B.V. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908852/
https://www.ncbi.nlm.nih.gov/pubmed/35283215
http://dx.doi.org/10.1016/j.jhep.2022.02.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908852/
https://www.ncbi.nlm.nih.gov/pubmed/35283215
http://dx.doi.org/10.1016/j.jhep.2022.02.015

Ejemplares similares